Poolbeg Provides Daniel Hoft to Scientific Advisory Board

Pharmaceutical firm specializing in infectious ailments on the medical stage Poolbeg introduced Thursday the appointment of Daniel Hoft to its scientific advisory board.

The AIM-listed firm mentioned Hoft is the Dianna and J. Joseph Adorjan Chair in Infectious Ailments and Immunology, and Director of the Division of Infectious Ailments, Allergy symptoms and Immunology on the College. of Drugs from the College of Saint Louis (SLU).

He mentioned he has labored in immunology and infectious ailments for 32 years and has revealed greater than 140 peer-reviewed scientific publications.

Hoft would be a part of the Scientific Advisory Board alongside Elaine Sullivan and Luke O’Neill, and with “in depth expertise” in infectious ailments, immunology and vaccinology, would assist information the corporate in its improvement packages. lively.

He would additionally work with the corporate to analysis potential licensing alternatives.

“Professor Hoft is a superb addition to Poolbeg’s Scientific Advisory Board, becoming a member of Dr Elaine Sullivan and Professor Luke O’Neill,” mentioned Managing Director Jeremy Skillington.

“His experience within the space of ​​infectious ailments, significantly extreme influenza and vaccine improvement, will likely be invaluable as we develop Poolbeg’s portfolio of property. “

Dr Skillington mentioned he would additionally work with the corporate to analysis potential property to acquire and develop.

“Professor Hoft is a extremely revered knowledgeable inside our trade, and we stay up for working with him as we proceed our journey of progress. “

As of 11:36 GMT, shares of Poolbeg Pharma have been down 0.26% to 9.73p.

About Edith J.

Check Also

Europe’s vitality disaster set to worsen as winter approaches

Via Rachel Morison to 11/28/2021 LONDON (Bloomberg) – Vitality costs in Europe are repeatedly breaking …